I had initial concerns for the study design being too exclusive and it looks like this is being addressed. Simple updates like theses are easy to do and don't take much time.
While not having any eligible subjects enrolled is disappointing, it is not unexpected. More sites coming online as promised is also great and first enrolment getting closer.
It's good to see management listening and upping their reporting efforts.
IBX Price at posting:
14.0¢ Sentiment: Hold Disclosure: Held
